PhD Researchers
손예준3.jpg
손예준 Yejun Son, PhD Researcher, dlstod9981@naver.com
정밀의료학, 디지털헬스, 의료빅데이터, 인공지능, 메타분석
​

· 수상이력

2026 아산사회복지재단 보건의료정책분야 장학생 선발 (박사)
​2025 Research Fellow, New York University
2025 한빛사 4회 선정
2025 평통장학재단 장학생 선발
2025 제 6회 고황스콜라 포스터 학술제 / 발표 우수상 수상
2025 Khreative U+ SDGs 연구 지원 선정 / 팀리더​
2024 한국연구재단 이공분야 학술연구지원사업 (석사과정생연구장려금지원) 선정 / 연구책임자
2024 ISPEs 아시아약물역학컨퍼런스 Scholarship 선정
2024 평통장학재단 장학생 선발
​2024 인공지능융합혁신인재양성 자율과제 선정 / 팀리더
2024 Khreative U+ SDGs 연구 지원 선정 / 팀리더

· 논문

2026
38. Global Incidence and Prevalence of Trigeminal Neuralgia, 1945-2024: A Systematic Review and Meta-Regression Analysis. J Clin Neurol. 2026 (제 1 저자; IF 3.1)

2025
37. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study. Nat Med. 2025 (제 1 저자; IF 58.7)
36. Biomarkers for Alzheimer’s disease across diverse biological domains: an umbrella review and evidence map. J Adv Res. 2025 (제 1 저자; IF 13.0)
35. Global prevalence of congenital color vision deficiency among children and adolescents, 1932-2022. Ophthalmology. 2025 (제 1 저자; IF 9.5)
34. Long-term trends in the prevalence of cardiovascular-kidney-metabolic syndrome in South Korea, 2011-2021: a representative longitudinal serial study. Lancet Reg Health West Pac. 2025 (제 1 저자; IF 7.6)
33. Postacute Sequelae of COVID-19 Across 12 Major Health Domains and 141 Diseases in Individuals With Mental Illness Among COVID-19 Survivors: A Population-Based Cohort Study in South Korea. J Med Virol. 2025 (제 1 저자; IF 6.8)
32. Post-Acute Sequelae of COVID-19 on Alopecia Areata in Individuals With Mental Illness in South Korea and Japan: A Binational Population-Based Cohort Study. J Med Virol. 2025 (제 1 저자; IF 6.8)
31. Post-Acute Sequelae of COVID-19 on Irritable Bowel Syndrome in Individuals With Mental Illness in South Korea: A Population-Based Cohort Study. J Med Virol. 2025 (제 1 저자; IF 6.8)
30. Efficacy and safety of glucagon-like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials. Diabetes Obes Metab. 2025 (교신저자; IF 5.7)
29. Global, regional, and national burden of cervical cancer in 2022 and projections to 2050: a population-based analysis of GLOBOCAN. Int J Gynecol Cancer. 2025 (제 1 저자; IF 4.7)
28. National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022. Sci Rep. 2025 (제 1 저자; IF 4.6)
27. Global and regional estimates of vaccine-associated herpes zoster and their related vaccines from 1969 to 2023. Sci Rep. 2025 (제 1 저자; IF 4.6)
26. Prevalence of Current, Daily, and Heavy Smokers Among Adolescents in 97 Countries: A Global Population-Based Study. J Adolesc Health. 2025 (교신저자; IF 4.5) 
25. Effects of photobiomodulation on multiple health outcomes: an umbrella review of randomized clinical trials. Syst Rev. 2025 (제 1 저자; IF 3.9)
24. Temporal trends and patterns in suicidal ideation among adolescents in 23 countries from 2003 to 2021. Sci Rep. 2025 (제 1 저자; IF 3.9)
2​3. Global prevalence of cannabis and amphetamine/methamphetamine use among adolescents in 47 countries: a population-based study from WHO database. World J Pediatr. 2025 (제 1 저자; IF 3.6)
22. Nationwide Trends in Screen Time and Associated Risk Factors by Family Structures Among Adolescents, 2008-2022: Nationwide Cross-Sectional Study. JMIR Public Health Surveill. 2025 (제 1 저자; IF 3.5)
21. Global burden of brain and central nervous system cancer in 185 countries, and projections up to 2050: a population-based systematic analysis of GLOBOCAN 2022. J Neurooncol. 2025 (제 1 저자; IF 3.1)
20. Correlation of Income Instability With 12 Non-Communicable Disease Risks in Korea: A Prospective Cohort Study. J Korean Med Sci. 2025 (제 1 저자; IF 3.0)
19. Global, Regional, and National Burden of Pharyngeal Cancer and Projections to 2050 in 185 Countries: A Population-Based Systematic Analysis of GLOBOCAN 2022. J Korean Med Sci. 2025 (제 1 저자; IF 3.0)
18. Non-Linear Association Between Physical Activities and Type 2 Diabetes in 2.4 Million Korean Population, 2009-2022: A Nationwide Representative Study. J Korean Med Sci. 2025 (제 1 저자; IF 3.0)
17. Dose-response association between physical activity and diagnosed hypertension in 2.4 million Korean population: Korea Community Health Survey 2009-2022. Clin Hypertens. 2025 (교신저자; IF 2.6)
16. Global Prevalence of Combustible Cigarettes and Noncombustible Nicotine or Tobacco Products Use Among Adolescents, 2014-2021. J Korean Med Sci. 2025 (제 1 저자; IF 2.3)
15. Cardiovascular risk across stages of cardiovascular-kidney-metabolic syndrome in South Korea, 2002-2022: A population-based cohort study. Medicine (Baltimore). 2025 (제 1 저자; IF 1.4)

2024
14. Risks of alopecia areata in long COVID: Binational population-based cohort studies from South Korea and Japan. J Med Virol. 2024 (제 1 저자; IF 12.7)
13. Machine Learning-Based Prediction of Suicidal Thinking in Adolescents by Derivation and Validation in 3 Independent Worldwide Cohorts: Algorithm Development and Validation Study. J Med Internet Res. 2024 (제 1 저자; IF 7.4)
12. National trends of allergic diseases and pandemic-related factors among individuals with obesity in South Korea: A nationwide representative serial study, 2005-2021. Heliyon. 2024 (제 1 저자; IF 4.0)
11. Longitudinal trends in depression, suicidal ideation, and suicide attempts by family structure in South Korean adolescents, 2009-2022: A nationally representative serial study. Asian J Psychiatr. 2024 (교신저자; IF 3.8)
10. Global association of secondhand smoke exposure locations and smoking behaviour among adolescents in 99 countries. Acta Paediatr. 2024 (제 1 저자; IF 3.8)
9. Association Between Sociodemographic Factors and Vaccine Acceptance for Influenza and SARS-CoV-2 in South Korea: Nationwide Cross-Sectional Study. JMIR Public Health Surveill. 2024 (제 1 저자; IF 3.5)
8. Sex-Specific Trends in the Prevalence of Osteoarthritis and Rheumatoid Arthritis From 2005 to 2021 in South Korea: Nationwide Cross-Sectional Study. JMIR Public Health Surveill. 2024 (제 1 저자; IF 3.5)
7. Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes in South Korea (1998 to 2022): Nationwide Cross-Sectional Study. JMIR Public Health Surveill. 2024 (제 1 저자; IF 3.5)
6. Comparison of national trends in physical activity among adolescents before and during the COVID-19 pandemic: A nationally representative serial study in South Korea. Heliyon. 2024 (제 1 저자; IF 3.4)
5. Sex differences in the global burden of multidrug- resistant tuberculosis without extensive drug resistance in the general population and people living with HIV/AIDS, 1990-2019. Eur Rev Med Pharmacol Sci. 2024 (제 1 저자; IF 3.3)
4. Racial Discrimination and Multiple Health Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses. Med Princ Pract. 2024 (제 1 저자; IF 2.9)
3. Association of Soda Drinks and Fast Food with Allergic Diseases in Korean Adolescents: A Nationwide Representative Study. Int Arch Allergy Immunol. 2024 (제 1 저자; IF 2.5)
2. Temporal changes in smoking prevalence among adolescents across 23 countries. Acta Paediatr. 2024 (제 1 저자; IF 2.4)
1. Biomarkers and Related Factors for the Diagnosis, Risk of Coronary Artery Lesions, and Resistance to Intravenous Immunoglobulin in Kawasaki Disease: An Umbrella Review of Meta-Analyses. Pediatr Cardio . 2024 (제 1 저자; IF 1.5)
adqeadzcad.jpg
이경민 Kyeongmin Lee, PhD Researcher, dlrudals0502@naver.com
규제과학, 의료빅데이터, 디지털헬스, 의료정보학
​

· 수상이력

2025 한빛사 4회 선정
2025 평통여성장학재단 장학생 선발
2025 ISPEs 아시아약물역학컨퍼런스 Scholarship 선정
2025 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2024 평통여성장학재단 장학생 선발

· 논문

2025
14. Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study. Eur Heart J. (제 1저자; IF 39.3)
13. Effectiveness of the live zoster vaccine in patients with type 2 diabetes: A nationwide emulated target trial. Clin Microbiol Infect. (제 1저자; IF 10.9)         
12. Global burden of antidepressant-associated seizures from 1967 to 2023: A comparative analysis of the international pharmacovigilance database. J Affect Disord. 2025 (제 1 저자; IF 4.9)
11. Adverse drug reaction patterns of GLP-1 receptor agonists approved for obesity treatment: Disproportionality analysis from global pharmacovigilance database. Diabetes Obes Metab. 2025 (제 1 저자; IF 5.4)

2024
10. Global burden of vaccine-associated angioedema and their related vaccines, 1967-2023: Findings from the global pharmacovigilance database. Allergy. 2024 (제 1 저자; IF 12.7)
9. Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database. J Med Virol. 2024 (제 1 저자; IF 12.7)
8. Associations between weight-control methods and depression among Korean adolescents: a study based on a national dataset. Nutr Res Pract. 2024 (제 1 저자; IF 2.0)
7. National trends in thyroid disease and COVID-19 pandemic-related factors, 1998-2021: A nationwide representative study in South Korea. Heliyon. 2024 (제 1 저자; IF 3.4)
6. National Trends in the Prevalence of Self-Perceived Overweight Among Adolescents Between 2005 and 2022: Nationwide Representative Study. JMIR Public Health Surveill. 2024 (제 1 저자; IF 3.5)
5. Global and Regional Burden of Vaccine-Associated Erythema Multiforme and Their Related Vaccines, 1967-2023: An In-Depth Analysis of the World Health Organization Pharmacovigilance Database. Med Princ Pract. 2024 (교신저자; IF 2.9)
4. Global burden of ADHD medication-associated cardiovascular disease, 1967-2023: A comparative analysis using the WHO pharmacovigilance database. Asian J Psychiatr. 2024 (제 1 저자; IF 3.8)
3. Association between glucagon-like peptide-1 receptor agonists and risk of suicidality: A comprehensive analysis of the global pharmacovigilance database. Diabetes Obes Metab. 2024 (제 1 저자; IF 5.4)
2. Global burden of anticancer drug-induced acute kidney injury and tubulointerstitial nephritis from 1967 to 2023. Sci Rep. 2024 (제 1 저자; IF 4.6)
1. Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967-2023. J Med Virol. 2024 (제 1 저자; IF 6.8)
zxcasdqwe.png
김소은 Soeun Kim, PhD Researcher, soeun9342@naver.com
의료데이터사이언스, 디지털헬스, 의료빅데이터, 인공지능
​

· 수상이력

2026 Research Fellow, New York University
2026 한빛사 8회 선정
2026 아산사회복지재단 보건의료정책분야 장학생 선발 (박사)
2026 Khreative U+ S-FUN(Star FacUlty Nurturing) 해외 연구연수 지원 선정
2025 평통여성장학재단 장학생 선발
2025 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2024 평통여성장학재단 장학생 선발
2024 Khreative U+ SDGs 연구 지원 선정 / 팀리더

· 논문

2026
25. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990-2023: a Global Burden of Disease study. Nat Med. 2026 (제 1저자; IF 50.0)
24. Deep learning-based survival outcomes of REBOA vs resuscitative thoracotomy in trauma: a nationwide cohort study in South Korea. Int J Surg. 2026 (제 1저자; IF 10.3)

2025
23. Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050. Lancet Respir Med. 2025 (제 1저자; IF 38.7)
22. A Multimodal Predictive Model for Chronic Kidney Disease and Its Association With Vascular Complications in Patients With Type 2 Diabetes: Model Development and Validation Study in South Korea and the U.K. Diabetes Care. 2025 (제 1저자; IF 16.6)
21. Method-specific suicide mortality rates among older adults in 47 countries and territories, 1996-2021, with projections to 2050: a global time series and modelling study. Lancet Healthy Longev. 2025 (제 1저자; IF 14.6)
20. Temporal trends and patterns in mortality from falls across 59 high-income and upper-middle-income countries, 1990-2021, with projections up to 2040: a global time-series analysis and modelling study. Lancet Healthy Longev. 2025 (제 1저자; IF 13.4)
19. Global, regional, and national burden of headache disorders, 1990-2021, with forecasts to 2050: A Global Burden of Disease study 2021. Cell Rep Med. 2025 (제 1저자; IF 10.6)
18. Global burden of anxiety, depression, self-harm (1990-2021) and the impact of COVID-19 pandemic. J Affect Disord. 2025 (제 1저자; IF 4.9)
17. Global Prevalence of Functional Abdominal Pain Disorder among Children and Adolescents According to the Rome III and IV Criteria: A Systematic Review and Meta-Analysis. Gut Liver. 2025 (제 1저자; IF 3.6)
16. Global cancer mortality among children, adolescents, and young adults from 77 countries, 1990-2021: a global time-series analysis and modelling study. World J Pediatr. 2025 (제 1저자; IF 3.6)
15. Method-specific suicide mortality rates among older adults in 47 countries and territories, 1996-2021, with projections to 2050: a global time series and modelling study. Lancet Healthy Longev. 2025 (제 1저자; IF 14.6)
​14. A Multimodal Predictive Model for Chronic Kidney Disease and Its Association With Vascular Complications in Patients With Type 2 Diabetes: Model Development and Validation Study in South Korea and the U.K. Diabetes Care. 2025 (제 1저자; IF 16.6)
13. Global, Regional, and National Trends in Maternal Mortality Ratio Across 37 High Income Countries From 1990 to 2021, With Projections up to 2050: A Comprehensive Analysis From the WHO Mortality Database. J Korean Med Sci. 2025 (제 1저자; IF 3.0)
12. Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050. Lancet Respir Med. 2025 (제 1저자; IF 38.7)
11. Machine Learning-Based Prediction of Substance Use in Adolescents in Three Independent Worldwide Cohorts: Algorithm Development and Validation Study. J Med Internet Res. 2025 (제 1저자; IF 7.4)
10. Temporal trends and patterns in mortality from falls across 59 high-income and upper-middle-income countries, 1990-2021, with projections up to 2040: a global time-series analysis and modelling study
 Lancet Healthy Longev. 2025 (제 1저자; IF 13.4)
9. Global, regional, and national trends in drug use disorder mortality rates across 73 countries from 1990 to 2021, with projections up to 2040: a global time-series analysis and modelling study. EClinicalMedicine. 2024 (제 1저자; IF 9.6)

2024
8. Global, Regional, and National Trends in Liver Disease-Related Mortality Across 112 Countries From 1990 to 2021, With Projections to 2050: Comprehensive Analysis of the WHO Mortality Database. J Korean Med Sci. 2024 (교신저자; IF 3.0)
7. Global Incidence and Prevalence of Chronic Rhinosinusitis: A Systematic Review. Clin Exp Allergy. 2024. (제 1저자; IF 6.3)
6. National Trends in the Prevalence of Unmet Health Care and Dental Care Needs During the COVID-19 Pandemic: Longitudinal Study in South Korea, 2009-2022. JMIR Public Health Surveill. 2024. (제 1저자; IF 3.5)
5. Psychosocial alterations during the COVID-19 pandemic and the global burden of anxiety and major depressive disorders in adolescents, 1990-2021: challenges in mental health amid socioeconomic disparities. World J Pediatr. 2024. (제 1저자; IF 6.1)
4. Global public concern of childhood and adolescence suicide: a new perspective and new strategies for suicide prevention in the post-pandemic era. World J Pediatr. 2024. (제 1저자; IF 6.1)

2023
3. Global incidence and prevalence of eosinophilic esophagitis, 1976-2022, and projections to 2037: a post-hoc analysis. Clin Gastroenterol Hepatol. 2023. (제 1저자; IF 12.6)
2. National and regional trends in the prevalence of type 2 diabetes and associated risk factors among Korean adults, 2009-2021. Sci Rep. 2023. (제 1저자; IF 4.6)
1. National trends in body mass index, overweight, and obesity among adults before and during the COVID-19 pandemic in 2009-2021: A representative longitudinal serial study in South Korea. J Med Virol. 2023. (제 1저자; IF 20.693)
슬라이드2.PNG
박재유 Jaeyu Park, PhD Researcher, qkrwodb980@gmail.com
디지털헬스, 의료빅데이터, 인공지능, 머신러닝, 의료정보학
​

· 수상이력

2026 한빛사 10회 선정
2025 Research Fellow, New York University 
2025 아산사회복지재단 보건의료정책분야 장학생 선발 (박사)
2025 제2회 미래 규제과학 신진연구자 최우수상 수상
2025 KHU Presidential Research Fellowship
2025 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2024 아산사회복지재단 보건의료정책분야 장학생 선발 (석사)
2024 ISPEs 아시아약물역학컨퍼런스 Full Scholarship 선정
2024 제 27회 규제과학혁신연구센터 국제공동 심포지엄 / 최우수 포스터상 수상
​2024 제 31회 대한기초의학 학술대회 / 우수 포스터상 수상
2024 인공지능융합혁신인재양성 자율과제 선정 / 팀리더
2024 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2024 대한비만학회 춘계학술대회 우수구연상 수상
2023 인공지능융합혁신인재양성 자율과제 선정 

· 논문

2026
56. Burden of chronic respiratory disease in Asia, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Respir Med. 2026 (제 1저자; IF 32.8)
55. Maternal Opioid Use and Subsequent Risk of Allergic Diseases in Children: Emulation of Target Trials Using the Korean Nationwide Birth Cohort. Allergy. 2026 (교신저자; IF 12.0)
54. National trends of unmet healthcare needs and risk factors by household income level, 2010 to 2022: A Nationwide cross-sectional study in South Korea. Medicine (Baltimore). 2026 (제 1저자; IF 1.5)
​
2025
53. TOP10-SCAR: A Global Pharmacovigilance Study on Medications Most Frequently Related to Severe Cutaneous Adverse Reactions. Allergy. 2025 (제 1저자; IF 12.6)
52. Identification of the Top 15 Drugs Associated With Anaphylaxis: A Pharmacovigilance Study. Clin Exp Allergy. 2025 (제 1저자; IF 5.2)
51. Global Burden of Drug-Induced Severe Cutaneous Adverse Reactions Associated With 33 Classes of Antibiotics (1968-2024): An Analysis of International Pharmacovigilance Reports. Clin Exp Allergy. 2025 (제 1저자; IF 5.2)
50. Postacute Sequelae of COVID-19 Across 12 Major Health Domains and 141 Diseases in Individuals With Mental Illness Among COVID-19 Survivors: A Population-Based Cohort Study in South Korea. J Med Virol. 2025 (제 1저자; IF 4.6)
49. Post-Acute Sequelae of COVID-19 on Alopecia Areata in Individuals With Mental Illness in South Korea and Japan: A Binational Population-Based Cohort Study. J Med Virol. 2025 (제 1저자; IF 4.6)
48. Post-Acute Sequelae of COVID-19 on Irritable Bowel Syndrome in Individuals With Mental Illness in South Korea: A Population-Based Cohort Study. J Med Virol. 2025 (제 1저자; IF 4.6)
47. National trends in the unmet healthcare needs among patients with hypertension or type 2 diabetes mellitus in Korea from 2009 to 2023. Sci Rep. 2025 (제 1저자; IF 3.8)
46. Top 10 drugs most frequently associated with adverse events of myocarditis and pericarditis. Sci Rep. 2025 (제 1저자; IF 3.8)
45. Global and regional estimates of vaccine-associated herpes zoster and their related vaccines from 1969 to 2023. Sci Rep. 2025 (제 1저자; IF 3.8)
44. Artificial intelligence models predicting abnormal uterine bleeding after COVID-19 vaccination. Sci Rep. 2025 (제 1저자; IF 3.8)
43. Development and Validation of a Machine Learning Algorithm for Predicting Diabetes Retinopathy in Patients With Type 2 Diabetes: Algorithm Development Study. JMIR Med Inform. 2025 (제 1저자; IF 3.1)
42. Disproportionality analysis from World Health Organization data on migraine-specific medications and cerebrovascular diseases. Eur J Clin Pharmacol. 2025 (제 1저자; IF 2.4)
41. Global Burden of Vaccine-Associated Cerebrovascular Venous Sinus Thrombosis, 1968-2024: A Critical Analysis From the WHO Global Pharmacovigilance Database. J Korean Med Sci. 2025 (제 1저자; IF 2.3)
40. Association of Unmet Healthcare Needs With Depressive Symptoms and COVID-19 Pandemic-Related Factors Among Adults, 2009-2022: A Nationwide Study in Korea. J Korean Med Sci. 2025 (제 1저자; IF 2.3)
39. Global burden of TNF-α inhibitors associated demyelinating diseases: A global disproportionality analysis. Medicine (Baltimore). 2025 (제 1저자; IF 1.4)
38. National trends in the prevalence of hypertension and diabetes stratified by sleep duration in South Korea, 2009-2022: A nationwide cross-sectional study: Trends and association of sleep duration in hypertension and diabetes. Medicine (Baltimore). 2025 (제 1저자; IF 1.4)

2024
37. Acute and post-acute respiratory complications of SARS-CoV-2 infection: population-based cohort study in South Korea and Japan. Nat Commun. 2024 (제 1저자; IF 16.6)
36. Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multi-nationwide cohort study from South Korea, Japan, and the UK. Clin Mol Hepatol. 2024 (제 1저자; IF 14.0)
35. Global burden of vaccine-associated multiple sclerosis, 1967-2022: A comprehensive analysis of the international pharmacovigilance database. J Med Virol. 2024 (제 1저자; IF 12.7)
34. Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database. J Med Virol. 2024 (제 1저자; IF 12.7)
33. Risks of cutaneous immune-related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK. J Med Virol. 2024 (제 1저자; IF 12.7)
32. National trends in counseling for stress and depression and COVID-19 pandemic-related factors among adults, 2009-2022: a nationwide study in South Korea: Stress and depression and pandemic. Psychiatry Res. 2024 (제 1저자; IF 11.3)
31. Comorbid health outcomes in patients with schizophrenia: an umbrella review of systematic reviews and meta-analyses. Mol Psychiatry. 2024 (제 1저자; IF 9.6)
30. National trends in alcohol consumption, smoking, suicide attempts, and COVID-19 pandemic-related factors among South Korean adolescents, 2012-2022. Asian J Psychiatr. 2024 (제 1저자; IF 9.5)
29. Risks of chronic urticaria following SARS-CoV-2 infection: binational population-based cohort studies from South Korea and Japan. J Allergy Clin Immunol Pract. 2024 (교신저자; IF 9.4)
28. Machine Learning-Based Prediction of Suicidality in Adolescents With Allergic Rhinitis: Derivation and Validation in 2 Independent Nationwide Cohorts. J Med Internet Res. 2024 (제 1저자; IF 7.4)
27. Nationwide trends in sadness, suicidal ideation, and suicide attempts among multicultural and monocultural adolescents in South Korea during the COVID-19 pandemic, 2011-2022. World J Pediatr. 2024 (제 1저자; IF 6.1)
26. Global Estimates of Reported Vaccine-Associated Ischemic Stroke for 1969-2023: A Comprehensive Analysis of the World Health Organization Global Pharmacovigilance Database. J Stroke. 2024 (제 1저자; IF 6.0)
25. National prevalence of atopic dermatitis in Korean adolescents from 2009 to 2022. Sci Rep. 2024 (제 1저자; IF 4.6)
24. National prevalence and trends in food labeling awareness, comprehension, usage, and COVID-19 pandemic-related factors in South Korea, 2014–2022. Sci Rep. 2024 (제 1저자; IF 4.6)
23. National trends in rheumatoid arthritis and osteoarthritis prevalence in South Korea, 1998–2021. Sci Rep. 2024 (제 1저자; IF 4.6)
22. Prenatal and postnatal exposure to antibiotics and risk of food allergy in the offspring: A nationwide birth cohort study in South Korea. Pediatr Allergy Immunol. 2024 (제 1저자; IF 4.4; Editor Choice)
21. Prenatal and infant exposure to antibiotics and subsequent risk of neuropsychiatric disorders in children: A nationwide birth cohort study in South Korea. Psychiatry Res. 2024 (제 1저자; IF 4.2)
20. Global Burden of Vaccine-Associated Chronic Urticaria, 2010-2023: From the Global Pharmacovigilance Database. Allergy Asthma Immunol Res. 2024 (제 1저자; IF 4.1)
19. National trends of allergic diseases and pandemic–related factors among individuals with obesity in South Korea: A nationwide representative serial study, 2005–2021. Heliyon. 2024 (제 1저자; IF 4.0)
18. Global burden of vaccine-associated uveitis and their related vaccines, 1967-2023. Br J Ophthalmol. 2024 (제 1저자; IF 3.8)
17. Predictive model for abdominal liposuction volume in patients with obesity using machine learning in a longitudinal multi-center study in Korea. Sci Rep. 2024 (제 1저자; IF 3.8)
16. National trends in adolescents' mental health by income level in South Korea, pre- and post-COVID-19, 2006-2022. Sci Rep. 2024 (제 1저자; IF 3.8)
15. Global public concern of childhood and adolescence suicide: a new perspective and new strategies for suicide prevention in the post-pandemic era. World J Pediatr. 2024 (제 1저자; IF 3.6)
14. Sex-Specific Trends in the Prevalence of Osteoarthritis and Rheumatoid Arthritis From 2005 to 2021 in South Korea: Nationwide Cross-Sectional Study.  JMIR Public Health Surveill. 2024 (제 1저자; IF 3.5)
13. Comparison of national trends in physical activity among adolescents before and during the COVID-19 pandemic: A nationally representative serial study in South Korea. Heliyon. 2024 (제 1저자; IF 3.4)
12. National trends in thyroid disease and COVID-19 pandemic-related factors, 1998-2021: A nationwide representative study in South Korea. Heliyon. 2024 (제 1저자; IF 3.4)
11. National trends in the prevalence of hepatitis B and C in South Korea, before and during the COVID-19 pandemic (2007-2021)–a nationwide representative study. Eur Rev Med Pharmacol Sci. 2024 (제 1저자; IF 3.3)
10. Sex differences in the global burden of multidrug- resistant tuberculosis without extensive drug resistance in the general population and people living with HIV/AIDS, 1990-2019. Eur Rev Med Pharmacol Sci. 2024 (제 1저자; IF 3.3)
9. Global, Regional, and National Trends in Liver Disease-Related Mortality Across 112 Countries From 1990 to 2021, With Projections to 2050: Comprehensive Analysis of the WHO Mortality Database. J Korean Med Sci. 2024 (제 1저자; IF 3.0)
8. National Trends in Allergic Rhinitis and Chronic Rhinosinusitis and COVID-19 Pandemic-Related Factors in South Korea, from 1998 to 2021. Int Arch Allergy Immunol. 2024 (교신저자; IF 2.8; Editor Choice)
7. National Trends and Prevalence of Atopic Dermatitis and Pandemic-Related Factors among Korean Adults, 2007–2021. Int Arch Allergy Immunol. 2024 (제 1저자; IF 2.8)
6. Association of Soda Drinks and Fast Food with Allergic Diseases in Korean Adolescents: A Nationwide Representative Study. Int Arch Allergy Immunol. 2024 (교신저자; IF 2.8)
5. Global estimates of vaccine-associated hepatic autoimmune disorders and their related vaccines, 1968-2024: An international analysis of the WHO pharmacovigilance database. Int Arch Allergy Immunol. 2024 (제 1저자; IF 2.5)
4. Global burden of vaccine-associated rheumatic diseases and their related vaccines, 1967-2023: A comprehensive analysis of the international pharmacovigilance database. Int J Rheum Dis. 2024 (제 1저자; IF 2.4)

2023
3. National trends in depression and suicide attempts and COVID-19 pandemic-related factors, 1998–2021: A nationwide study in South Korea. Asian J Psychiatr. 2023 (제 1저자; IF 9.5)
2. National trends in asthma prevalence in South Korea before and during the COVID-19 pandemic, 1998-2021. Clin Exp Allergy. 2023 (제 1저자; IF 6.1)
1. Global and regional burden of vaccine-induced thrombotic thrombocytopenia, 1969–2023: Comprehensive findings with critical analysis of the international pharmacovigilance database. Eur J Haematol. 2024 (교신저자; IF 3.1)
슬라이드3.PNG
김현진 Hyeon Jin Kim, PhD Researcher, hyeonjin7418@gmail.com
데이터 사이언스, 디지털헬스, 의료빅데이터, 인공지능, 임상시험
​

· 수상이력

2026 한빛사 11회 선정
2024-2025 Research Fellow, Massachusetts General Hospital & Harvard Medical School 
2025 대학원대통령과학장학금 장학생 선발 (박사)
2025 한국연구재단 이공분야 학술연구지원사업(박사과정생연구장려금지원) 선정 / 연구책임자
2025 제2회 미래 규제과학 신진연구자 대상 수상
2025 KHU Presidential Research Fellowship
2025 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2024 아산사회복지재단 보건의료정책분야 장학생 선발 (석사)
2024 경희대학교 우수학위논문상 수상 (석사)
2023 사회적가치연구원 (CSES) 펠로우 6기 / 우수펠로우 
2023 인공지능융합혁신인재양성 자율과제 선정 / 팀리더

· 논문

2026
25. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study. Nat Med. 2026 (제 1저자; IF 50.0)
24. Maternal Opioid Use and Subsequent Risk of Allergic Diseases in Children: Emulation of Target Trials Using the Korean Nationwide Birth Cohort. Allergy. 2026 (제 1저자; IF 12.0)
​
2025
23. Global, regional, and national trends in drug use disorder mortality rates across 73 countries from 1990 to 2021, with projections up to 2040: a global time-series analysis and modelling study. eClinicalMedicine. 2025 (교신저자; IF 9.6)
22. Global, regional and national trends in suicide mortality rates across 102 countries from 1990 to 2021 with projections up to 2050. Nat. Ment. Health. 2025 (교신저자; IF 8.7)
21. Final Report on the Safety and Efficacy of Poly-L-Lactic Acid Filler (Gana V) Injection for the Correction of Nasolabial Fold: A Double-Blind, Non-Inferiority, Randomized, Split-Face Controlled Trial. Aesthetic Plast Surg. 2025 (제 1저자; IF 2.8)
20. Prospective Efficacy of Cutotype-Specific Personalized Topical Postbiotic Emollients in Females: A Single-Center, Cluster-Based, Pre-Post, Nonrandomized Controlled Trial in South Korea. J Cosmet Dermatol. 2025 (제 1저자; IF 2.3)
19. Association of Everyday Discrimination With Drug Use During the COVID-19 Pandemic in the All of Us Research Program. Psychiatry Investig. 2025 (제 1저자)
​
2024
18. Prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea. BMJ. 2024 (제 1저자; IF 107.7)
17. Incident allergic diseases in post-COVID-19 condition: multinational cohort studies from South Korea, Japan and the UK. Nat Commun. 2024 (제 1저자; IF 16.6)
16. Acute and post-acute respiratory complications of SARS-CoV-2 infection: population-based cohort study in South Korea and Japan. Nat Commun. 2024 (제 1저자; IF 16.6)
15. Global burden of vaccine-associated multiple sclerosis, 1967-2022: A comprehensive analysis of the international pharmacovigilance database. J Med Virol. 2024 (제 1저자; IF 12.7)
14. Risks of cutaneous immune-related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK. J Med Virol. 2024 (교신저자; IF 12.7)
13. Efficacy and safety of topical Streptococcus postbiotic emollient in adolescents and adults with mild-to-moderate atopic dermatitis: A randomized, double-blind, vehicle-controlled trial. Allergy. 2024 (제 1저자; IF 12.4)
12. Comorbid health outcomes in patients with schizophrenia: an umbrella review of systematic reviews and meta-analyses. Mol Psychiatry. 2024 (제 1저자; IF 9.6)
11. National prevalence and trends in food labeling awareness, comprehension, usage, and COVID-19 pandemic-related factors in South Korea, 2014-2022. Sci Rep. 2024 (교신저자; IF 4.6)
10. Opioid use and subsequent delirium risk in patients with advanced cancer in palliative care: a multicenter registry study. Sci Rep. 2024 (제 1저자; IF 4.6)
9. Global, Regional, and National Burden of Spine Pain, 1990-2019: A Systematic Analysis of the Global Burden of Disease Study 2019. Arch Phys Med Rehabil. 2024 (제 1저자; IF 4.3)
8. Prenatal and infant exposure to antibiotics and subsequent risk of neuropsychiatric disorders in children: A nationwide birth cohort study in South Korea. Psychiatry Res. 2024 (제 1저자; IF 4.2)
7. Sex differences in the global burden of multidrug- resistant tuberculosis without extensive drug resistance in the general population and people living with HIV/AIDS, 1990-2019. Eur Rev Med Pharmacol Sci. 2024 (교신저자; IF 3.3)
6. Post Hoc Non-inferiority Analysis of the Efficacy of Poly-L-Lactic Acid Filler (Gana V versus Sculptra) Injection for Correction of the Nasolabial Fold: A Double-Blind, Randomized, Split-Face Controlled Trial. Aesthetic Plast Surg. 2024 (제 1저자; IF 2.0)
​
2023
5. National Trends in Physical Activity Among Adults in South Korea Before and During the COVID-19 Pandemic, 2009-2021. JAMA Netw Open. 2023 (제 1저자; IF 13.8)
4. National trends in body mass index, overweight, and obesity among adults before and during the COVID-19 pandemic in 2009-2021: A representative longitudinal serial study in South Korea. J Med Virol. 2023 (제 1저자; IF 12.7)
3. National trends in the prevalence of chronic kidney disease among Korean adults, 2007-2020. Sci Rep. 2023 (제 1저자; IF 4.6)
2. Safety and Efficacy of Poly-L-Lactic Acid Filler (Gana V vs. Sculptra) Injection for Correction of the Nasolabial Fold: A Double-Blind, Non-Inferiority, Randomized, Split-Face Controlled Trial. Aesthetic Plast Surg. 2023 (제 1저자; IF 2.7)
1. Risk factors for delirium among patients with advanced cancer in palliative care: a multicenter, patient-based registry cohort in South Korea. Eur Rev Med Pharmacol Sci. 2023 (제 1 저자; IF 3.3)
슬라이드1.PNG
이하연 Hayeon Lee, PhD Researcher, wwhy28@khu.ac.kr
생체의공학, 생체신호, 디지털헬스, 의료빅데이터, 인공지능
​

· 수상이력

2025 Research Fellow, New York University 
2025 31문화재단 장학생 선발 (박사)
2025 대학원대통령과학장학금 장학생 선발 (박사)
2024 대한민국 인재상 수상
2024 한빛사 15회 선정
2024 Khreative U+ SDGs 연구 지원 선정 / 팀리더
2024 31문화재단 장학생 선발 (석사)
2024 경희대학교 우수학위논문상 수상 (석사)
2024 대한의료정보학회장상 수상
2024 EAACI Congress Award (유럽알레르기면역학회) 수상
2024 83회 일본예방의학회 International Award 수상
2024 제 31회 대한기초의학 학술대회 / 우수 구연상 수상
2024 경희대학교 2024 제 5회 고황스콜라 학술제 / 우수 구연상 수상
2023 보건장학재단 장학생 선발
2023 인공지능융합혁신인재양성 자율과제 선정 / 팀리더
2022 딥노이드 AI 코딩대회 우승

· 논문

2025
35. Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study. Eur Heart J. (교신저자; IF 38.1)
34. Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study. Circulation. (교신저자; IF 37.8)
33. Live Zoster Vaccination and the Reduced Risk of Chronic Respiratory Diseases: An Emulated Target Trial. Allergy. (교신저자; IF 12.0)
32. Effectiveness of the live zoster vaccine in patients with type 2 diabetes: A nationwide emulated target trial. Clin Microbiol Infect. (교신저자; IF 10.9)
31. Prediction model for type 2 diabetes mellitus and its association with mortality using machine learning in three independent cohorts from South Korea, Japan, and the UK: a model development and validation study. EClinicalMedicine. (제 1저자; IF 9.6)
30. Post-Acute Sequelae of COVID-19 on Irritable Bowel Syndrome in Individuals With Mental Illness in South Korea: A Population-Based Cohort Study. J Med Virol. (교신저자; IF 6.8)
29. Post-Acute Sequelae of COVID-19 on Alopecia Areata in Individuals With Mental Illness in South Korea and Japan: A Binational Population-Based Cohort Study. J Med Virol. (교신저자; IF 6.8)
28. Postacute Sequelae of COVID-19 Across 12 Major Health Domains and 141 Diseases in Individuals With Mental Illness Among COVID-19 Survivors: A Population-Based Cohort Study in South Korea. J Med Virol. (교신저자; IF 6.8)
27. Artificial intelligence models predicting abnormal uterine bleeding after COVID-19 vaccination. Sci Rep. (교신저자; IF 3.8)
26. Global burden of vaccine-associated kidney injury using an international pharmacovigilance database Sci Rep. (제 1저자; IF 3.8)
25. Burden of post-acute sequelae of COVID-19 in patients with type 2 diabetes: a binational cohort study in South Korea and Japan. Int J Infect Dis. (교신저자; IF XX)
24. Long-term effectiveness of live zoster vaccine against herpes zoster and related complications: a nationwide emulated target trial in South Korea. Vaccine. (교신저자; IF 3.5)

2024
23. Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19: A Binational Cohort Study. Ann Intern Med. 2024 (교신저자; IF 39.2)
22. Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan. Nat Hum Behav (교신저자; IF 29.9)
21. Incident allergic diseases in post-COVID-19 condition: multinational cohort studies from South Korea, Japan and the UK. Nat Commun. 2024 (교신저자; IF 16.6)
20. Acute and post-acute respiratory complications of SARS-CoV-2 infection: population-based cohort study in South Korea and Japan. Nat Commun. 2024 (교신저자; IF 16.6)
19. Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multi-nationwide cohort study from South Korea, Japan, and the UK. Clin Mol Hepatol. 2024 (교신저자; IF 14.0)
18. Global burden of vaccine-associated angioedema and their related vaccines, 1967-2023: Findings from the global pharmacovigilance database. Allergy. 2024 (교신저자; IF 12.7)
17. Risks of alopecia areata in long COVID: Binational population-based cohort studies from South Korea and Japan. J Med Virol. 2024 (교신저자; IF 12.7)
16. Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database. J Med Virol. 2024 (교신저자; IF 12.7)
15. Risks of cutaneous immune-related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK. J Med Virol. 2024 (교신저자; IF 12.7)
14. Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database. J Med Virol. 2024 (제 1저자; IF 12.7)
13. Global burden of vaccine-associated anaphylaxis and their related vaccines, 1967–2023: A comprehensive analysis of the international pharmacovigilance database. Allergy. 2024 (제 1저자; IF 12.4)
12. Global burden of vaccine-associated alopecia, 1979-2023: a comprehensive analysis of the international pharmacovigilance database. Br J Dermatol. 2024 (교신저자; IF 10.1)
11. Risks of chronic urticaria following SARS-CoV-2 infection: binational population-based cohort studies from South Korea and Japan. J Allergy Clin Immunol Pract. 2024 (교신저자; IF 9.4)
10. Machine Learning-Based Prediction of Suicidality in Adolescents With Allergic Rhinitis: Derivation and Validation in 2 Independent Nationwide Cohorts. J Med Internet Res. 2024 (교신저자; IF 7.4)
9. Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967-2023. J Med Virol. 2024 (교신저자; IF 6.8)
8. Machine Learning-Based Prediction for Incident Hypertension Based on Regular Health Checkup Data: Derivation and Validation in 2 Independent Nationwide Cohorts in South Korea and Japan. J Med Internet Res. 2024 (제 1저자; IF 5.8)
7. Machine learning-based model to predict delirium in patients with advanced cancer treated with palliative care: a multicenter, patient-based registry cohort. Sci Rep. 2024 (제 1저자; IF 4.6)
6. Global burden of anticancer drug-induced acute kidney injury and tubulointerstitial nephritis from 1967 to 2023. Sci Rep. 2024 (교신저자; IF 4.6)
5. Global Burden of Vaccine-Associated Chronic Urticaria, 2010-2023: From the Global Pharmacovigilance Database. Allergy Asthma Immunol Res. 2024 (교신저자; IF 4.1)
4. Global and Regional Burden of Vaccine-Associated Erythema Multiforme and Their Related Vaccines, 1967-2023: An In-Depth Analysis of the World Health Organization Pharmacovigilance Database. Med Princ Pract. 2024 (교신저자; IF 2.9)
3. Assessing the interplay of contrast, defocus, and resolution in cryo-EM: a benchmark experiment for limited dataset screening. J Anal Sci Technol. 2024 (제 1저자; IF 2.4)

2023
2. Machine learning-based prediction of suicidality in adolescents during the COVID-19 pandemic (2020-2021): Derivation and validation in two independent nationwide cohorts. Asian J Psychiatr. 2023 (제 1저자; IF 9.5)
1. Quantification of identifying cognitive impairment using olfactory-stimulated functional near-infrared spectroscopy with machine learning: a post hoc analysis of a diagnostic trial and validation of an external additional trial. Alzheimers Res Ther. 2023 (제 1저자; IF 9.0)